HURN · Huron Consulting Group Inc.

$121.37 +4.86 (+4.17%) At close · Jul 28

Market Cap

$1.89B

16.21M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$1.7B +11.7%

FY2025

Net Income

$105.04M -9.9%

FY2025

Gross Margin

6.4% -1.6pp

FY2020

Operating Margin

10.51% -0.6pp

FY2025

Diluted EPS

$5.84 -6.9%

FY2025

Operating Cash Flow

$193.39M -3.9%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
Revenue	+13.6%	+14.3%	+8.3%	$1.85B – $1.89B	$1.75B	$1.7B^G	$1.52B	$1.4B	$1.16B	$926.96M	$871.01M	$965.47M	$878M	$807.75M	$797.98M	$769.02M	$889.21M	$787.79M	$681.73M	$657.89M	$604.6M
Cost of Revenue	+2.8%	+4.8%	+4.3%	—	—	—	—	—	—	$661.95M	$624.71M	$669.67M	$608.71M	$541.17M	$524.45M	$488.64M	$582.92M	$513.95M	$444.47M	$433.12M	$399.21M
Gross Profit	-8.0%	-6.0%	—	—	—	—	—	—	—	—	$55.71M	$77.32M	$71.83M	$71.54M	$60.09M	$75.96M	$69.58M	$81.75M	$73.07M	—	—
Gross Margin	—	—	—	—	—	—	—	—	—	—	6.4%	8.01%	8.18%	8.86%	7.53%	9.88%	7.83%	10.38%	10.72%	—	—
Selling, General & Administrative	+14.9%	+13.3%	+7.3%	—	$326.09M	$318.02M	$286.66M	$257.49M	$209.38M	$177.89M	$170.69M	$203.07M	$180.98M	$175.36M	$160.2M	$157.9M	$155.43M	$138.54M	$125.27M	$119.33M	$113.79M
Amortization of Intangibles	+0.3%	-2.3%	-8.9%	—	$13.2M	$11.3M	$6.5M	$8.2M	$11.2M	$9.3M	$12.7M	$17.8M	$24M	$35M	$33.1M	$28.7M	$11.1M	$6.8M	$0	—	—
Depreciation & Amortization	+5.8%	+1.4%	-5.7%	—	$35.2M	$32.43M	$25.3M	$24.94M	$27.36M	$25.98M	$30.22M	$34.41M	$39.31M	$50.09M	$46.82M	$58.05M	$30.99M	$23.61M	$25.25M	$24.72M	$22.86M
Restructuring Charges	-2.7%	-14.9%	-3.5%	—	$8.46M	$9.14M	$9.91M	$11.55M	$9.91M	$12.4M	$20.53M	$1.86M	$3.66M	$6.25M	$9.59M	$13.03M	$3.44M	$761K	$4M	$3.83M	$4.06M
Total Operating Expenses	-0.8%	+1.3%	+2.3%	—	—	—	—	—	—	$212.17M	$275.15M	$232.1M	$217.2M	$474.03M	$199.31M	$176.89M	$183.3M	—	$163.82M	$169.33M	$162.44M
Total Costs & Expenses	+12.8%	—	—	—	$1.56B	$1.52B	$1.35B	$1.27B	$1.06B	—	—	—	—	—	—	—	—	—	—	—	—
Operating Income	+21.4%	—	+5.6%	—	$182.42M	$178.57M	$168.82M	$125.35M	$99.76M	$52.84M	-$28.85M	$63.71M	$52.1M	-$207.46M	$74.23M	$103.5M	$123M	$119.91M	$73.44M	$55.45M	$42.96M
Operating Margin	—	—	—	—	—	10.51%	11.09%	8.96%	8.61%	5.7%	-3.31%	6.6%	5.93%	-25.68%	9.3%	13.46%	13.83%	15.22%	10.77%	8.43%	7.1%
EBITDA	+18.4%	+173.8%	+2.7%	—	$217.62M	$211M	$194.12M	$150.29M	$127.12M	$78.82M	$1.37M	$98.11M	$91.41M	-$157.37M	$121.05M	$161.55M	$153.99M	$143.51M	$98.69M	$80.16M	$65.82M
Other Non-Operating Income	—	—	—	—	-$41.73M	-$43.49M	-$14.8M	-$41.45M	$8.82M	$27.2M	-$5.02M	-$11.22M	-$26.88M	-$15.05M	-$15.08M	-$19.93M	-$8.39M	-$6.27M	-$7.8M	-$12.34M	-$14.14M
Pretax Income	+7.6%	—	+4.9%	—	$140.69M	$135.08M	$154.02M	$83.9M	$108.58M	$80.04M	-$33.87M	$52.49M	$25.22M	-$222.5M	$59.16M	$83.57M	$114.61M	$113.64M	$65.65M	$43.11M	$28.82M
Income Tax	-3.1%	—	+3.3%	—	$36.94M	$30.04M	$37.39M	$21.42M	$33.03M	$17.05M	-$10.16M	$10.51M	$11.28M	-$52M	$19.68M	$21.67M	$35.56M	$47.18M	$29.7M	$21.63M	$16.43M
Net Income	+11.6%	—	+5.9%	—	$103.75M	$105.04M	$116.63M	$62.48M	$75.55M	$62.99M	-$23.84M	$41.74M	$13.65M	-$170.12M	$37.62M	$59.05M	$79.05M	$66.43M	$36.43M	$20.52M	$8.53M
Net Margin	—	—	—	—	—	6.18%	7.66%	4.47%	6.52%	6.8%	-2.74%	4.32%	1.55%	-21.06%	4.71%	7.68%	8.89%	8.43%	5.34%	3.12%	1.41%
Comprehensive Income	+4.2%	—	+2.9%	—	$97.01M	$86.99M	$105.69M	$67.19M	$76.83M	$66.77M	-$25.72M	$40.18M	$19.77M	-$163.36M	$37.65M	$65.29M	$77.19M	$67M	$36.28M	$21.27M	$7.36M
EPS (Basic) USD/shares	+17.3%	—	+8.5%	—	—	$6.02	$6.52	$3.32	$3.73	$2.94	-$1.09	$1.90	$0.63	-$7.93	$1.78	$2.67	$3.52	$2.98	$1.66	$0.96	$0.41
EPS (Diluted) USD/shares	+17.1%	—	+8.4%	—	—	$5.84^G	$6.27	$3.19	$3.64	$2.89	-$1.09	$1.85	$0.62	-$7.93	$1.76	$2.61	$3.45	$2.92	$1.63	$0.95	$0.41
Shares Outstanding (Basic Avg) shares	-4.8%	-4.4%	-2.4%	—	—	17.45M	17.89M	18.83M	20.25M	21.44M	21.88M	21.99M	21.71M	21.44M	21.08M	22.14M	22.43M	22.32M	21.91M	21.32M	20.55M
Shares Outstanding (Diluted Avg) shares	-4.6%	-3.8%	-2.3%	—	—	17.99M	18.61M	19.6M	20.75M	21.81M	21.88M	22.51M	22.06M	21.44M	21.42M	22.6M	22.93M	22.78M	22.29M	21.68M	20.77M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: $624.63M in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

1.56×

Peer median 1.32×

EV/EBIT

14.89×

Peer median 14.19×

P/E (TTM)

19.92×

Peer median 16.92×

Peer medians compare against the 9 similar-size Consulting Services companies (of 20 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Healthcare	$858,422,000	$777,437,000	$696,313,000	$551,346,000	$444,767,000	$406,536,000	$399,221,000	$364,763,000
Education	$509,509,000	$483,541,000	$438,892,000	$365,823,000	$242,374,000	$223,325,000	$225,028,000	$194,177,000
Commercial	$331,212,000	$260,827,000	$263,550,000	$241,792,000	$218,499,000	$214,266,000	—	—
Business Advisory	—	—	—	—	$291,663,000	$267,361,000	$252,508,000	$236,185,000
Health Care	—	—	—	—	—	—	$399,221,000	$364,763,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Healthcare	$255,582,000	$208,928,000	$172,900,000	$131,227,000	$118,324,000	$105,650,000	$125,724,000	$108,060,000
Education	$113,186,000	$108,521,000	$99,098,000	$78,924,000	$52,398,000	$45,780,000	$55,741,000	$48,243,000
Commercial	$55,857,000	$51,198,000	$54,202,000	$50,025,000	$34,296,000	$39,044,000	—	—
Business Advisory	—	—	—	—	$48,236,000	$48,046,000	$49,695,000	$50,625,000
Health Care	—	—	—	—	—	—	$125,724,000	$108,060,000

Operating Margin by Segment (%)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Healthcare	29.8%	26.9%	24.8%	23.8%	26.6%	26%	31.5%	29.6%
Education	22.2%	22.4%	22.6%	21.6%	21.6%	20.5%	24.8%	24.8%
Commercial	16.9%	19.6%	20.6%	20.7%	15.7%	18.2%	—	—
Business Advisory	—	—	—	—	16.5%	18%	19.7%	21.4%
Health Care	—	—	—	—	—	—	31.5%	29.6%

Key facts CIK 1289848 CUSIP 447462102 13F (30d) 32 filings 32 filers Visit website Investor relations